Neoadjuvant Epirubicin, Cyclophosphamide, and Paclitaxel With or Without Gemcitabine in Treating Women Who Are Undergoing Surgery for Early Breast Cancer
This study is ongoing, but not recruiting participants.
Study NCT00070278
Information provided by National Cancer Institute (NCI)
First Received: October 3, 2003
Last Updated: February 14, 2009
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
